In vitro evidence that β-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 1, 2000, Pages 29-38

  Strazielle, Nathalie ^b   Ghersi Egea, Jean Francois ^b   Ghiso, Jorge ^d   Dehouck, Marie Pierre ^c   Frangione, Blas ^d   Patlak, Clifford ^e   Fenstermacher, Joseph ^f   Gorevic, Peter ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITÉ LYON 1   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e STONY BROOK UNIVERSITY   (United States)

^f HENRY FORD HOSPITAL   (United States)

Author keywords

Alzheimer disease; Blood brain barrier; In vitro models; Toxicity; amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN; MACROGOL;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CAPILLARY PERMEABILITY; CATTLE; COCULTURE; DIFFUSION; ENDOTHELIUM CELL; MONOLAYER CULTURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT;

EID: 0033973997     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.1.29     Document Type: Article

References (60)

1. Vinters HV. Cerebral amyloid angiopathy: A critical review. Stroke 1987;18:311-24
2. Glenner G, Wong W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-90
3. Kang J, Lemaire H, Unterbeck A, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325:503-7
4. Weidermann A, Konig G, Bunke D, et al. Identification, biogenesis and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 1989;57:115-26
5. Seubert P, Vigo-Pelfrey C, Esch F, et al. Isolation and quantitation of soluble Alzheimer's β-peptide from biological fluids. Nature 1992;359:325-27
6. Shoji M, Golde TE, Ghiso J, et al. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 1992;258:126-29
7. Prelli F, Castano E, Glenner GG, Frangione B. Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem 1988;51:648-51
8. Miller DL, Papayannopoumos IA, Styles J, Bobin SA. Peptide composition of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 1993;301: 41-52
9. Roher AE, Lowenson JD, Clarke S, et al. β-amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:10836-40
10. Gravina SA, Ho L, Eckman CB, et al. Amyloid β protein (Aβ) in Alzheimer's disease brain. J Biol Chem 1995;270:7013-16
11. 42 in cerebrovascular deposits. Amyloid: Int J Clin Invest 1995; 2:234-40
12. Shinkai Y, Yoshimura M, Ito Y, et al. Amyloid β-proteins 1-40 and 1-42(43) in the soluble fraction of extra-and intracranial blood vessels. Ann Neurol 1995;38:421-28
13. Tabaton M, Nunzi MG, Xue R, Usiak M, Autilio-Gambetti L, Gambetti P. Soluble amyloid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem Biophys Res Commun 1994;200:1592-1603
14. Teller JK, Russo C, DeBusk LM, et al. Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down's syndrome. Nature Medicine 1996;2:93-96
15. Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y. High tissue content of soluble β-40 is linked to cerebral amyloid angiopathy. Am J Pathol 1994;145:452-60
16. Siman R, Card JP, Nelson RB, Davis LG. Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron 1989;3:275-85
17. Selkoe DJ. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 1998;8: 447-53
18. Natte R, de Boer WI, Maat-Schieman ML, et al. Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls. Brain Res 1999;828:179-83
19. Zlokovic BV, Ghiso J, Mackic JB, McComb JG, Weiss MH, Frangione B. Blood-brain barrier transport of circulating Alzheimer's amyloid β. Biochem Biophys Res Commun 1993;197:1034-40
20. Maness LM, Banks WA, Podlisny MB, Selkoe DJ, Kastin AJ. Passage of human amyloid β-protein 1-40 across the murine blood-brain barrier. Life Sci 1994;55:1643-50
21. Martel CL, Mackic JB, McComb JG, Ghiso J, Zlokovic BV. Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid β in guinea pigs. Neurosci Lett 1996;206:157-60
22. Poduslo JF, Curran GL, Haggard JJ, Biere AL, Selkoe DJ. Permeability and residual plasma volume of human. Dutch variant, and rat amyloid β-protein 1-40 at the blood-brain barrier. Neurobiol Dis 1997;4:27-34
23. 1-40/ vector complex. Proc Natl Acad Sci USA 1995;92:10227-31
24. Ghersi-Egea JF, Gorevic PD, Ghiso J, Frangione B, Patlak CS, Fenstermacher JD. Fate of cerebrospinal fluid-borne amyloid β-peptide: Rapid clearance into blood and appreciable accumulation by cerebral arteries. J Neurochem 1996;67:880-83
25. Dehouck MP, Meresse S, Dehouck B, Fruchart JC, Cecchelli R. In vitro reconstituted blood-brain barrier. J Control Rel 1992;21: 81-92
26. Dehouck B, Dehouck MP, Fruchart JC, Cecchelli R. Upregulation of the low-density lipoprotein receptor at the blood-brain barrier: Intercommunications between brain capillary endothelial cells and astrocytes. J Cell Biol 1994;126:465-73
27. Beck DW, Vinters HV, Hart MN, Cancilla PA. Glial cells influence polarity of the blood-brain barrier. J Neuropathol Exp Neurol 1984;43:219-24
28. Dehouck MP, Méresse S, Delorme P, Fruchart JC, Cecchelli R. An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J Neurochem 1990;54:1798-1801
29. Matsubara E, Soto C, Governale S, Frangione B, Ghiso J. Apolipoprotein J and Alzheimer's amyloid β solubility. Biochem J 1995;316:671-79
30. Soto C, Castano E, Kumar R, Beavis R, Frangione B. Fibrillogenesis of synthetic amyloid β-peptides is dependent on initial secondary structure. Neurosci Lett 1995;200:105-8
31. Meresse S, Dehouck MP, Delorme P, et al. Bovine brain endothelial cells express tight junction and monoamine oxidase activity in long-term culture. J Neurochem 1989;53:1363-71
32. Booher J, Sensenbrenner M. Growth and cultivation of dissociated neurons and glial cells from embryonic chick, rat and human brain in flask cultures. Neurobiology 1972;2:97-10540
33. Dehouck MP, Meresse S, Delorme P, Torpier G, Fruchart JC, Cecchelli R. The blood-brain barrier in vitro: Coculture of brain capillary endothelial cells and astrocytes. Circulation et metabolisme du cerveau 1990;7:151-62
34. Siflinger-Birnboim A, Del Vecchio PJ, Cooper JA, Blumenstock FA, Shepard JM, Malik AB. Molecular sieving characteristics of the cultured endothelial monolayer. J Cell Physiol 1987;132: 111-17
35. Dehouck MP, Jolliet-Riant P, Bree F, Fruchart JC, Cecchelli R, Tillement JP. Drug transfer across the blood-barrier: Correlation between "in vitro" and "in vivo" models. J Neurochem 1992;58: 1790-97
36. Descamps L, Dehouck MP, Torpier G, Cecchelli R. Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. Am J Physiol 1996:270:H1149-H1158
37. Levin VA, Fenstermacher JD, Patlak CS. Sucrose and inulin space measurements of the cerbral cortex in four mammalian species. Am J Physiol 1970;291:1528-33
38. Johnstone EM, Chancy MO, Norris FH, Pascual R, Little SP. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear, and five other mammals by cross-species polymerase chain reaction analysis. Mol Brain Res 1991;10: 299-305
39. Savage MJ, Trusko SP, Howland DS, et al. Turnover of amyloid b-protein in mouse brain and acute reduction of its level by phorbol ester. J Neurosci 1998;18:1743-52
40. Petrov T, Howarth AG, Krukoff TL, Stevenson BR. Distribution of the tight junction-associated protein ZO-1 in circumventricular organs of the CNS. Brain Res Mol Brain Res 1994;(3-4):235-46
41. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A. Cell internalization of the third helix of the antennapedia homeodomain is receptor-independant. J Biol Chem 1996;271: 18188-93
42. Derossi D, Chassaing G, Prochiantz A. Trojan peptides: The penetrating system for intracellular delivery. Trends Cell Biol 1998;8: 84-87
43. Grieg NH, Genka S, Daly EM, Rappoport SI. Physico-chemical and pharmacokinetic parameters of seven lipophylic chlorambucil esters designed for brain penetration. Cancer Chemotherap Pharmacol 1990;25:311-19
44. Pappenheimer JR, Renkin EM, Borrero LM. Filtration, diffusion, and molecular sieving through peripheral capillary membranes. A contribution to the pore theory of capillary permeability. Am J Physiol 1951;167:13-46
45. Fenstermacher JD, Johnson JA. Filtration and reflection coefficients of the rabbit blood-brain barrier. Amer J Physiol 1966;210:341-46
46. Biere AJ, Ostaszewski B, Stimson ER, Hyman BT, Maggio JE, Selkoe DJ. Amyloid β-peptide is transported on lipoproteins and albumin in human plasma. J Biol Chem 1996;271:32916-22
47. Zlokovic BV, Martel CL, Mackic JB, et al. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. Biochem Biophys Res Commun 1994;205:1431-37
48. Martel CL, Mackic JB, Matsubara E, et al. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid. J Neurochem 1997;69:1995-2004
49. Chopineau J, Robert S, Fenard L, et al. Monoacylation of ribonuclease A enables its transport across an in vitro model of the blood-brain barrier. J Control Rel 1998;56:231-37
50. Fillebeen C, Descamps L, Dehouck MP, et al. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem 1999;274:7011-17
51. Blanc EM, Toborek M, Mark RJ, Hennig B, Mattson MP. Amyloid β-peptide induces cell monolayer albumin permeablity, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J Neurochem 1997;68:1870-81
52. Yan SD, Chen X, Fu M, et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 1996;382:685-91
53. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996;380:168-71
54. Stewart PA, Hayakawa K, Akers MA, Vinters HV. A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab Invest 1992;67:734-42
55. Vinters HV, Secor DL, Read SL, et al. Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: An immunohistochemical and ultrastructural study. Ultrastructural Pathol 1994;18:333-48
56. Mackic JB, Weiss MH, Miao W, et al. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid β peptide in aged squirrel monkey with cerebral amyloid angiopathy. J Neurochem 1998;70:210-15
57. Rubinstein E. Relationship of senescence of cerebrospinal fluid circulatory system to dementia of the aged. Lancet 1998;351:283-85
58. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy: Amyloid beta accumulates in putative interstitial drainage pathways in Alzheimer's disease. Am J Pathol 1998;153:725-33
59. Zhang, ET, Richards HK, Kida S, Weller RO. Directional and compartmentalized drainage of interstitial fluid and cerebrospinal fluid from the rat brain. Acta Neuropathol 1992;83:233-39
60. Ghersi-Egea JF, Finnegan W, Chen JL, Fenstermacher JD. Rapid distribution of intraventricularly administered sucrose into cerebrospinal cisterns via subarachnoid velae in rats. Neuroscience 1996;75:1271-88